Loading clinical trials...
Loading clinical trials...
A Single-arm, Open-label Study to Evaluate a Procedure for Intra-articular (IA) Injection of FX006 in Patients With Osteoarthritis (OA) of the Hip
Conditions
Interventions
FX006 32 mg
Locations
5
United States
Noble Clinical Research
Tucson, Arizona, United States
Hope Clinical Research
Canoga Park, California, United States
Biosolutions Clinical Research Center
La Mesa, California, United States
Dream Team Clinical Research
Pomona, California, United States
Lenox Hill Hospital
New York, New York, United States
Start Date
July 30, 2019
Primary Completion Date
October 11, 2019
Completion Date
December 30, 2019
Last Updated
January 24, 2024
NCT05357378
NCT05700682
NCT06342843
NCT05169229
NCT06088160
NCT06578182
Lead Sponsor
Pacira Pharmaceuticals, Inc
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions